Title: CDC Pfizer bivalent COVID shot link to strokes - The Jerusalem Post
Date: Sun, 15 Jan 2023 16:31:00 GMT
URL: https://www.jpost.com/health-and-wellness/coronavirus/article-728616
Content: CDC Pfizer bivalent COVID shot link to strokes - The Jerusalem Post Israel News Health & Wellness WORLD NEWS Middle East Business & Innovation Opinion Podcast Login Log Out Aliyah Judaism Kabbalah Science Antisemitism Archeology Israel Real Estate Food Premium Buying Expert Advertisement Jerusalem Post Health & Wellness Coronavirus US FDA, CDC see early signal of possible Pfizer bivalent COVID shot link to stroke Health concerns rise as pattern shows people 65 and older were more likely to have an ischemic stroke 21 days after receiving the Pfizer/BioNTech bivalent shot By REUTERS Published: JANUARY 15, 2023 18:30 Updated: JANUARY 15, 2023 18:31 People pose with syringe with needle in front of displayed Pfizer logo in this illustration taken. (photo credit: REUTERS) Advertisement A safety monitoring system flagged that US drugmaker Pfizer Inc PFE.N and German partner BioNTech's BNTX.O updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to preliminary data analyzed by US health authorities.What are the potential health consequences of the vaccines?The US Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) said on Friday that a CDC vaccine database had uncovered a possible safety issue in which people 65 and older were more likely to have an ischemic stroke 21 days after receiving the Pfizer/BioNTech bivalent shot, compared with days 22-44.An ischemic stroke, also known as brain ischemia, is caused by blockages in arteries that carry blood to the brain. The FDA and CDC said that other large studies, the CDC's Vaccine Adverse Event Reporting System, other countries' databases and Pfizer-BioNTech's databases had not flagged this safety issue, adding that it requires more investigation."Although the totality of the data currently suggests that it is very unlikely that the signal in VSD (Vaccine Safety Datalink) represents a true clinical risk, we believe it is important to share this information with the public," the health authorities said.The Pfizer vaccine for children aged 5-11 (credit: AVSHALOM SASSONI/MAARIV)Although the totality of the data currently suggests that it is very unlikely that the signal in VSD (Vaccine Safety Datalink) represents a true clinical risk, we believe it is important to share this information with the publicCDC health authoritiesPfizer and BioNTech said in a statement that they have been made aware of limited reports of ischemic strokes in people 65 and older following vaccination with their updated shot. "Neither Pfizer and BioNTech nor the CDC or FDA have observed similar findings across numerous other monitoring systems in the US and globally and there is no evidence to conclude that ischemic stroke is associated with the use of the companies' COVID-19 vaccines," the companies added."Neither Pfizer and BioNTech nor the CDC or FDA have observed similar findings across numerous other monitoring systems in the US and globally and there is no evidence to conclude that ischemic stroke is associated with the use of the companies' COVID-19 vaccines"Pfizer and BioNTech spokespersonThis safety concern has not been identified with Moderna's MRNA.O bivalent shot and both the CDC and FDA continue to recommend that everyone aged 6Sign up for the Health & Wellness newsletter >> Tags vaccine COVID-19 Coronavirus Vaccine Pfizer vaccine efficacy covid Covid Headline Advertisement Hot Opinion The IDI report is an uphill battle needing a lot of focus - editorial By JPOST EDITORIAL Who should lead the struggle in Israel for the judiciary's defense? By AMOTZ ASA-EL Stop obsessing about how we older women look -opinion By ANDREA SAMUELS Less minority and civil rights will weaken liberty , not democracy - opinion By ALAN DERSHOWITZ Israel's High Court protects people from across the political spectrum - opinion By KYLIE EISMAN-LIFSCHITZ Advertisement Advertisement Most Read 1 Archaeologists believe they found the temple of Poseidon in Greece 2 Written records of biblical King David discovered by researchers 3 Have high cholesterol? Here are simple and effective tips to lower it 4 Russia's Vladimir Putin afraid of coup, will retire in 2023 - report 5 Artillery sinks Russian warship in Dnipro River, says Ukraine Advertisement Information About Us Contact us Feedback Terms Of Service Privacy Policy Subscriber Agreement JPost Jobs Cancel Subscription Sitemap פרסום בג'רוזלם פוסט Customer Service Advertise with Us The Jerusalem Post Group Breaking News Iran News Coronavirus World News IvritTalk- Free trial lesson The Jerusalem Report Jerusalem Post Lite Trending Articles Shapers of Israel Maariv Online Maariv News Israel Real Estate Special Content Promo Content Tools and services JPost Premium Ulpan Online JPost Newsletter Our Magazines Learn Hebrew RSS feed JPost.com Archive Digital Library Lists of Jewish holidays Law Sites Of Interest Poalim Online JNF-USA Buying Expert Electronics Home & Kitchen Appliances Health & Personal Care Tools & Home Improvement Sports & Outdoors Beauty Patio, Lawn & Garden Office Products Toys & Games The Jerusalem Post Customer Service Center can be contacted with any questions or requests: Telephone: *2421 * Extension 4 Jerusalem Post or 03-7619056 Fax: 03-5613699 E-mail: [email protected] The center is staffed and provides answers on Sundays through Thursdays between 07:00 AM and 14:00 PM and Fridays only handles distribution requests between 7:00 AM and 12:30 PM For international customers: The center is staffed and provides answers on Sundays through Thursdays between 7AM and 14PM Israel time Toll Free number 1-800-448-9291 Telephone +972-3-761-9056 Fax: 972-3-561-3699 E-mail: [email protected] Copyright © 2023 Jpost Inc. All rights reserved • Terms of Use • Privacy Policy Designed by
